Stephen is a scientific leader for advanced analytics and an internal consultant on driving innovation on drug development matters using state-of-the-art statistical methods across the R&D enterprise. His goal is to bring better medication to patients with a special emphasis on tailored therapeutics. Stephen's specialties include the use of statistics and mathematics in pharmaceutical drug development and commercialization.